- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/54 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 307/54
Total number of patents in this class: 300
10-year publication summary
39
|
20
|
31
|
15
|
26
|
19
|
16
|
13
|
12
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Salk Institute for Biological Studies | 445 |
10 |
ADT Pharmaceuticals, LLC | 13 |
8 |
Proteostasis Therapeutics, Inc. | 70 |
7 |
Vectus Biosystems Limited | 35 |
6 |
Corteva Agriscience LLC | 2662 |
6 |
The Regents of the University of California | 19857 |
5 |
Archer Daniels Midland Company | 1110 |
5 |
Mitobridge, Inc. | 34 |
5 |
Allergan, Inc. | 2356 |
4 |
President and Fellows of Harvard College | 5964 |
4 |
SK Biopharmaceuticals Co., Ltd. | 261 |
4 |
Toyama Chemical Co., Ltd. | 102 |
4 |
Janssen Pharmaceutica N.V. | 3396 |
3 |
Board of Regents, The University of Texas System | 5763 |
3 |
Chubu University Educational Foundation | 100 |
3 |
Kolon Industries, Inc. | 1673 |
3 |
Okinawa Institute of Science and Technology School Corporation | 155 |
3 |
Rhodia Operations | 1587 |
3 |
Rosalind Franklin University of Medicine and Science | 89 |
3 |
Sanford Burnham Prebys Medical Discovery Institute | 297 |
3 |
Other owners | 208 |